Epigral Limited has announced a conference call to discuss its Q3FY26 financial results, scheduled for Friday, January 30, 2026, at 5:00 PM IST. The company has formally notified both the National Stock Exchange of India Limited and BSE Limited about this upcoming investor interaction.

Regulatory Compliance and Notification

The company submitted the conference call intimation on January 23, 2026, in compliance with Regulation 30 and Para (A) of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Gaurang Trivedi (M. No. - A22307) signed the formal notification to the stock exchanges.

Management Participation

The Q3FY26 results discussion will feature key members of Epigral Limited's senior management team:

• Maulik Patel – Chairman and Managing Director
• Kaushal Soparkar – Executive Director
• Rakesh Agrawal – Chief Financial Officer
• Milind Kotecha – Investor Relations and Strategy

Conference Call Details

Emkay Global Financial Services Ltd is facilitating the conference call with comprehensive access arrangements for participants:

International Dial-in Access

The conference call provides extensive international toll-free access across multiple countries including Argentina, Australia, Belgium, Canada, China, France, Germany, Hong Kong, Italy, Japan, Netherlands, Poland, Singapore, South Korea, Sweden, Thailand, UK, and USA. Each country has dedicated toll-free numbers for seamless participation.

Contact Information

For additional information regarding the conference call, participants can contact Meet Vora at meet.vora@emkayglobal.com or call +91 22 6624 2474. The company encourages pre-registration to avoid wait times and enable express joining through the DiamondPass™ feature.

Epigral Limited has received an assessment order and demand notice from the Deputy Commissioner of Income Tax, Vadodara, amounting to ₹52.52 crores including applicable interest. The company disclosed this development through a regulatory filing under SEBI Listing Regulations on January 1, 2026.

Assessment Order Details

The income tax assessment pertains to Assessment Year 2022-23 for Financial Year 2021-22. The company received the order on December 31, 2025, which was passed under specific provisions of the Income-tax Act, 1961.

Company's Response and Position

Epigral Limited has stated that the assessment order is part of ordinary course assessment proceedings. The company maintains it has adequate factual and legal grounds to reasonably and technically substantiate its position in the matter.

The key aspects of the company's stance include:

• The consequent demand is not maintainable according to the company
• No financial impact expected on financials, operations, or other activities
• Process initiated to file rectification application and appeal within prescribed timelines

Financial Impact Assessment

According to the company's disclosure, there is no anticipated financial impact on the company's financials, operations, or other activities due to this assessment order. Epigral believes it has strong grounds to challenge the demand and expects to resolve the matter through proper legal channels.

Next Steps

The company is proceeding with filing both a rectification application and an appeal against the assessment order within the prescribed timelines as per income tax regulations. This approach indicates the company's confidence in its position and commitment to pursuing all available legal remedies to contest the demand.